Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT02186366
Eligibility Criteria:
Inclusion Criteria:
* Meet criteria for a primary diagnosis of current GAD as demonstrated by a structured clinical interview for Diagnostic and Statistical Manual -IV（DSM-IV）；meet a diagnosis of Deficiency of both heart and spleen type.
* The scores of SAS≥50, 24≥the scores of HAMD ≥15.
* The symptoms of anxiety have continued not less than 6months.
Exclusion Criteria:
* major depression, schizophrenia ,bipolar disease other psychotic disorders, drug-dependent persons;
* patients with severe suicidal tendencies;
* women in pregnancy or breastfeeding, menstrual or postpartum recovery;
* suffered from serious illness or impairment of system,such as heart and brain blood vessels, lungs, liver, kidneys and blood system.
* persons allergic to Buspirone and excipient;
* persons suffering from epilepsy or hypertension or Glaucoma or myasthenia gravis or leukopenia;
* persons must be taking monoamine oxidase inhibitors;
* persons who drink a lot;
* persons with the local skin lesions in abdomen damage (such as damage, Burns, etc);
* persons with abdominal visceral tumors, nodules, inflammation, edema, abdominal aortic atherosclerosis;
* persons without the incompetence or unable to read, write and understand independently;
* persons whom the researchers believe should not participate in this study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
50 Years
Study:
NCT02186366
Study Brief:
Protocol Section:
NCT02186366